097955:KRXCJ Cheiljedang Corporation Analysis
Data as of 2026-03-15 - not real-time
₩129,000.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
CJ Cheiljedang trades at a regular market price of 129,000 KRW, far below the DCF‑derived fair value of 444,085 KRW, indicating substantial upside potential. The stock’s price‑to‑sales ratio of 0.11 and a dividend yield of 4.69% further support a value‑oriented case. However, the company’s free cash flow is negative (‑562 bn KRW) and debt‑to‑equity sits at an elevated 104%, raising concerns about financial flexibility. Operating margins are thin at 4.66% and net profit margin barely exceeds 0.2%, reflecting modest profitability. Technicals are bearish: the price is under the 20‑day, 50‑day and 200‑day SMAs (136,400; 137,688; 140,249 KRW), the RSI is 35.5 (near‑oversold), and the MACD histogram is negative. Volume has remained stable, but daily turnover (5,789 shares) is below the 10‑day average, suggesting limited short‑term liquidity.
The consumer defensive sector generally cushions earnings during economic downturns, yet CJ’s heavy exposure to global commodity prices introduces geographic and currency sensitivities. A beta of 0.13 and 30‑day volatility of 25.5% point to low market‑beta risk but relatively high price swings. The payout ratio of 163% exceeds sustainable levels, and the negative free cash flow implies the current dividend may be at risk if cash generation does not improve. Given the stark valuation gap, the stock appears undervalued, but the financial strain tempers enthusiasm. For investors seeking income, the high yield is attractive only if the dividend can be maintained; for value hunters, the DCF upside provides a compelling long‑run thesis. Consequently, we recommend a short‑term hold pending confirmation of a bottom, a medium‑term hold as the company works through its balance‑sheet challenges, and a long‑term buy for those comfortable with the turnaround risk.
The consumer defensive sector generally cushions earnings during economic downturns, yet CJ’s heavy exposure to global commodity prices introduces geographic and currency sensitivities. A beta of 0.13 and 30‑day volatility of 25.5% point to low market‑beta risk but relatively high price swings. The payout ratio of 163% exceeds sustainable levels, and the negative free cash flow implies the current dividend may be at risk if cash generation does not improve. Given the stark valuation gap, the stock appears undervalued, but the financial strain tempers enthusiasm. For investors seeking income, the high yield is attractive only if the dividend can be maintained; for value hunters, the DCF upside provides a compelling long‑run thesis. Consequently, we recommend a short‑term hold pending confirmation of a bottom, a medium‑term hold as the company works through its balance‑sheet challenges, and a long‑term buy for those comfortable with the turnaround risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technicals (price below SMAs, negative MACD)
- Negative free cash flow
- High dividend yield but unsustainable payout
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Valuation gap remains wide
- Elevated debt load
- Need for cash‑flow stabilization
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF suggests >3x upside
- Consumer defensive sector resilience
- Potential turnaround in profitability
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin0.20%
ROE1.99%
ROA2.97%
Debt/Equity104.33
Op. Cash Flow₩2234.9B
Free Cash Flow₩-562370772992
Technical Analysis
TrendBearish
RSI35.5
Support₩125,500.00
Resistance₩144,200.00
MA 20₩136,400.00
MA 50₩137,688.00
MA 200₩140,248.50
MACDBearish
VolumeStable
Fear & Greed Index72.88
Valuation
Fair Value₩444,085.43
GradeUndervalued
TypeValue
Dividend Yield4.69%
Risk Assessment
Beta0.13
Volatility25.54%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.